<DOC>
	<DOC>NCT01520337</DOC>
	<brief_summary>Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets</brief_summary>
	<brief_title>Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy</brief_title>
	<detailed_description>Polyp detection rate in colonoscopy following oral administration of methylene blue MMX modified release tablets in subjects undergoing colonoscopy as outpatients.</detailed_description>
	<mesh_term>Polyps</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Patients scheduled for screening or surveillance colonoscopy. Written informed consent.Practising reliable contraception or sterile.Ability to understand and comply with the protocol. Pregnancy or lactation known or suspected hypersensitivity GI obstruction or perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin time,elevated serum creatinine.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>